Skip to main content

Advertisement

Log in

Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma

  • Radiotherapy
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

To preliminarily evaluate the feasibility, therapeutic effect and toxicity of stereotactic gamma-ray body radiation therapy (γ-SBRT) for asynchronous bilateral renal cell carcinoma (bRCC).

Materials and methods

A retrospective analysis was performed on the clinical data of nine patients with asynchronous bRCC who were unable to undergo surgery and received γ-SBRT between February 2002 and May 2012. A total dose of 36–51 Gy was delivered to the 50 % isodose line covering the planning target volume at 3–5 Gy/fraction, whereas a total dose of 60–85 Gy was delivered at 5–7 Gy/fraction to the gross target volume. The local control rate (LC) and overall survival rate (OS) were calculated using the Kaplan–Meier method.

Results

Patient follow-up ended in March 2013 and the follow-up rate was 100 %. Of the nine patients, none presented with complete remission and five (55.6 %) achieved partial remission. The objective response rate was 55.6 %. The 1-, 3- and 5-year LC rates were 64.8, 43.2 and 43.2 %, respectively. The 1-, 3- and 5-year OS rates were 66.7, 53.3 and 35.6 %, respectively. Four (44.4 %) patients had an acute radiation reaction; there were two cases of grade I leukocytopenia and two cases of grade I gastrointestinal reactions. Late radiation-induced toxicity consisted of grade II gastrointestinal reactions in two patients.

Conclusion

Stereotactic gamma-ray body radiation therapy was found to be safe and effective in the treatment of asynchronous bRCC. Improved prognosis will require individualised treatment and a combination of multiple therapeutic approaches; this will be a primary research trend in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Cairns P (2010) Renal cell carcinoma. Cancer Biomark 9:461–473

    PubMed  Google Scholar 

  2. Robson CJ (1963) Radical nephrectomy for renal cell carcinoma. J Urol 89:37–42

    CAS  PubMed  Google Scholar 

  3. McKiernan J, Simmons R, Katz J, Russo P (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59:816–820

    Article  PubMed  Google Scholar 

  4. Xia T, Li H, Sun Q et al (2006) Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66:117–125

    Article  PubMed  Google Scholar 

  5. Xia T, Li H, Wang Y et al (2007) Clinical outcome of whole body gamma knife therapy inoperable stage I/II non-small-cell lung cancer. Chin J Radiat Oncol 3:91–97

    Google Scholar 

  6. Chang D, Xia T, Li P et al (2009) Clinical outcome of whole body γ-knife for limited pancreatic carcinoma. Chin J Radiat Oncol 18:470–473

    Google Scholar 

  7. Li H, Wang Y, Li P, Wang X et al (2012) Clinical study of stereotactic gamma-ray body radiation therapy for patients with stage I/II non-small-cell lung cancer. Chin J Radiat Oncol 21:321–324

    CAS  Google Scholar 

  8. Kondziolka D, Ong JG, Lee JY et al (2009) Gamma knife thalamotomy for essential tremor. J Neurosurg 108:111–117

    Article  Google Scholar 

  9. Verheul JB, Hanssens PE, Lie ST et al (2010) Gamma knife surgery for trigeminal neuralgia: a review of 450 consecutive cases. J Neurosurg 113:160–167

    PubMed  Google Scholar 

  10. Niu X, Rajanbabu A, Delisle M et al (2013) Brain metastases in women with epithelial ovarian cancer: multimodal treatment including surgery or gamma-knife radiation is associated with prolonged survival. J Obstet Gynaecol Can 35:816–822

    PubMed  Google Scholar 

  11. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247

    Article  CAS  PubMed  Google Scholar 

  12. Eggener SE, Rubenstein JN, Smith ND et al (2004) Renal tumors in young adults. J Urol 171:106–110

    Article  CAS  PubMed  Google Scholar 

  13. Blute ML, Itano NB, Cheville JC et al (2003) The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol 169:1276–1281

    Article  PubMed  Google Scholar 

  14. Novick AC, Gephardt G, Guz B et al (1991) Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058–1062

    Article  CAS  PubMed  Google Scholar 

  15. Gong D, Li Z, Wang X et al (2007) Strategy in diagnosis and treatment of bilateral renal cell carcinoma. Chin J Urol 28:585–587

    Google Scholar 

  16. Patel MI, Simmons R, Kattan MW et al (2003) Long-term follow-up of bilateral sporadic renal tumors. Urology 61:921–925

    Article  PubMed  Google Scholar 

  17. Kume H, Oda H, Nakatsuru Y et al (2000) Genetic identification of bilateral primary or metastatic nonpapillary renal cell carcinoma. BJU Int 86:208–212

    Article  CAS  PubMed  Google Scholar 

  18. Hyman RA, Voges V, Finby N (1973) Bilateral hypernephroma. Am J Roentgenol Radium Ther Nucl Med 117:104–107

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared that no competing interests exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying-Jie Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, YJ., Han, TT., Xue, JX. et al. Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma. Radiol med 119, 878–883 (2014). https://doi.org/10.1007/s11547-014-0402-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-014-0402-3

Keywords

Navigation